Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

NCT02456012 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Peptic Ulcer Hemorrhage

Interventions

DRUG: oral esomeprazole 20 mg twice daily
DRUG: oral esomeprazole 20 mg once daily

Sponsor

Hsiu-Chi Cheng